stoxline Quote Chart Rank Option Currency Glossary
  
(MAIA)
  0 (0%)    07-26 19:59
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2024-07-26 4:45:38 PM
Short term     
Mid term     
Targets 6-month :  4.33 1-year :  4.94
Resists First :  3.71 Second :  4.22
Pivot price 3.63
Supports First :  2.88 Second :  2.39
MAs MA(5) :  3.53 MA(20) :  3.57
MA(100) :  2.97 MA(250) :  2.16
MACD MACD :  -0.1 Signal :  0
%K %D K(14,3) :  39.5 D(3) :  49.4
RSI RSI(14): 43.2
52-week High :  5.98 Low :  0.81
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ MAIA ] has closed above bottom band by 2.6%. Bollinger Bands are 42.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 3.53 - 3.55 3.55 - 3.57
Low: 3.25 - 3.28 3.28 - 3.3
Close: 3.27 - 3.31 3.31 - 3.34
Company Description

Headline News

Fri, 26 Jul 2024
H2H, prediction of Beatriz Haddad Maia vs Varvara Gracheva in Paris with odds, preview, pick | 27th July 2024 - Tennis Tonic

Fri, 26 Jul 2024
‘Want to know that I fenced my best': Philly's Maia Weintraub is on guard for Olympic gold - NBC Philadelphia

Wed, 24 Jul 2024
Jilma Olivenstein Obituary (1958 - 2024) - Miami, FL - Tribune Review - Legacy.com

Tue, 23 Jul 2024
Fencing community helps push Philadelphia’s Maia Weintraub to first Olympics - The Morning Call

Tue, 23 Jul 2024
MAIA Biotechnology's Lung Cancer Drug Shows Promising Long-Term Benefits In Advanced Patients - Benzinga

Tue, 23 Jul 2024
MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent - StockTitan

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 17 (M)
Shares Float 10 (M)
Held by Insiders 24.3 (%)
Held by Institutions 1.8 (%)
Shares Short 179 (K)
Shares Short P.Month 302 (K)
Stock Financials
EPS -1.45
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.2
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -103.3 %
Return on Equity (ttm) -243.9 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow -12 (M)
Levered Free Cash Flow -7 (M)
Stock Valuations
PE Ratio -2.3
PEG Ratio 0
Price to Book value 16.54
Price to Sales 0
Price to Cash Flow -4.85
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android